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Results: 483 patienu were enrolled in the study. The percentage ofpatients
receiving HAART increased from 37.1 % to 56.6% among patients with
CD4 cell count between 200 and 500 copies/mm3 and 15.3% to 31.5%
among patients with CD4 > 500 copies/mm3. Among patienU with AIDS
defining illness (AD!) and CD4 cell count less than 200 copies/mm3 at
enrolment, the percentage of patients receiving HAART remained stable.
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Patients with AIDS defining
illness (ADI); n - 122 88.5% 82.8% 85.3% 82.0%
CD4 < 200 copies/mm3, no
AD!; n = 114 68.4 71.9 62.3 64.0
CD4: 200-500 copies/mm3;
n = 123 37.1 51.6 53.2 56.5
CD4 > 500 copies/mm3,
n = 124 15.3 21.8 28.2 31.5
Conclusions: HAART could be considered under-utilised among patients
without AIDS defining illness in Italy betweenJune 1997 andJune 1998.
IMoP237I Patients on Highly Active Antiretroviral Therapy
(HAART) are more likely to remain employed in Italy
D. Yin!, F. Tediosi2,DiCinti02, F. Parazzini2, L. Garattini
I MeTck & Co., Inc. Whilehouse Station, United States; 2Mario Negri Institute
for Pharmaceutical Researchltaly
Objective: To estimate the association between HAART and employment
status among HIV-positive patients.
Methods: A multicenter, prospective observational study was conducted in
five hospitals located in three different regions ofItaly (1 from the South, 2
from Centre, 2 from the North) betweenJune 1997 andJune 1998. A total of
483 patients were stratified by CD4 cell count and AIDS status and ware
followed prospectively for one year. Data were collected every three months
by predesigned questionnaire. Information collected included patient char-
acteristics, CD4 cell count, viral load, opportunistic illnesses, healthcare
resource utilization, and employment status.
Results: At enrolment 241 ofthe 483 patients (50%) were an employee, self-
C:nl.ploycd, or a tcntporary W"orker. P3tientlt 'Who rect'!-iveO HAART were
more likely to remain employed during the one-year follow-up period (see
table). Multivariate logistic regression indicated that the likelihood of
remaining employed was associated with HAART (Odds Ratio = 2.9, P
= 0.0001), status ofAIDS defining illness (OR = 0.36, P = 0.0001) or CD4
< 200 cells/mm3 at enrolment (OR = 0.43, P = 0.0002).
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IWeP260IFirst description of the human granulocytic
ehrlichiosis in Croatia
L]. Misic-Majerus1, N. Bujicl , V. Madjaric', V.Janes-Poje'
1Department of Infeaious Diseases; General Hospital, Koprivnica, Croatia
Objective: To present epidemiological, clinical, laboratory characteristics
and diagnostic analysis of patients suffering from Human granulocytic
ehrlichiosis (HGE).
Methods: Fint patients affected with HGE, who have been hospitalised at
the Department of Infectious Diseases of the General Hospital in Kopriv-
nica-Croatia, during the 1998, were included in the analysis. Three man and
one woman aged from 17-67 were infected. The clinical picture,laboratory
findings and course of disease have been described in details. Specific
antimicrobial therapy was not administrated. Serological methods ofindir-
ect immunofluorescence assay (lFA) were used for diagnostic confirmation.
Results: HGE was self-contained disease in two patients. Clinically, it was
presented as non-specific. flu-like acute, febrile illna with leukopenia,
trombocytopcnia and moderately elevated aminotransferase values. In two
Conclusions: Employed HIV-positive patients who received HAART were
2.9 times more likely to remain employed than patients receiving non-
HAART therapy or no antiretroviral therapy.
IMoP23S1 Cost outcomes for HIV-associated wasting: Initial
treatment with somatropin V5. initial treatment with other
wasting treatments
V. Cafaro', C. de Guzman2• D. Gary2, E. Hamee, R. Slaker2, M. Lange2•
D. Lapins2
I Wellspring Medical Croup, San Francisco, CA; 2Clinkal Partners, San
Francisco, CA, United Slates
Objective: To analyze cost outcomes for patients receiving somatropin,
stratified by prior treatment for AIDS-related wasting.
Methods: Clinical Parmen (CP) is a national disease management company
providing data support and HIV case management for managed core
organizations. The CP database contains clinical data from chart audits
and electronic claims data. In an analysis of patients with AIDS-related
wasting, 38 patients began somatropin treatment between 1/1/1997 and 6/
30/1999. 18 patients received treatment for wasting using some combination
of testosterone, oxandrolone, and/or dronabinol prior to their treatment
with somatropin. Patients were stratified into "First-line somatropin" and
"First-line Other Wasting Treatment (OWT)" groups, and analyzed for
cost outcomes in an intent-to-treat analysis. All patients had evidence of
wasting syndrome (defined as loss of ~10% of body weight) by an HIV
dietitian; all were on stable antiretroviral therapy. CD4+ counts and viral
suppression rates before wasting treatment were comparable between the
groups.
Results: While average PPPM costs between the groups were similar prior
to wasting treatment, differences were evident during end afrer treatment
with somatropin. For patients in the First-line somatropin group, average
cost PPPM declined 27% ($1,859 to $1,356) following sornatropin treat-
ment. while costs rose 187% ($1,770 to $5,080) in the First-line OWTgroup.
Conclusions: In this cohort, patients initially treated with somatropin had
better cost outcomes than patients who initially received other wasting
treatment. Before firm conclusions can be drawn, a prospective trial
evaluating initial somatropin use vs. somatropin as secondary and cost
outcomes treatment should be initiated.
patients it was a coinfection. In one patient HGE was associated with Tick-
borne encephalitis (TBE) and in the another with Lyme disease (LB). Testing
sera for antibodies for Ehrlichia equi and HGE causative pathogen showed a
quadruple increase in the acute and covalescent phase of the disease.
Conclusion: This study presents fint proven patients with HGE in Croatia.
IWeP261! Sensitive PCR method to detect Babesia dlvergens
L. V. von Stedingkl, M. Gurtelschmid', M. Granstrom l ,]. Gray2
'Clin. Microbiol. Karol. Hosp. Stockholm, Sweden; 2Univ . College Dublin,
United Kingdom
Objectives: Babesiosis, primarily known to afflict wild and domestic
animals is being increasingly recognized as a human disease both in
Europe and in the United States. The intra-erythrocytic parasite Babesia
divergens is the predominant etiologic species in Europe and is transmitted
by the tick Ixodes ricinus. The aim ofthe study was to create a sensitive and
specific PCR method to detect B. divergens parasites in ticks and whole
blood samples.
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Methods: B. divergens DNA was extracted from whole blood and cruched
ticks by the use of QIAamp DNA Mini Kit(Qiagen). The DNA samples
were assayed in a newly designed semi-nested PCR system with specific
primers derived from the 18S rRNA gene ofB. divergens.
Results: The sensitivity of the nested PCR was established by testing
dilutions of B. divergens infected gerbil blood samples in human blood.
The test could deteet 0.()()()()()1 % parasitaemia. I. ricinus larvae allowed to
engorge on a gerbil infected with B. divergens were tested by PCR at 0, 14,
28, and 70 days after engorgement. B. divergens DNA could be detected in
all 30 larvae tested from the three first intervals. In the 70 days postengorge-
ment ticks, when the larvae were moulted into nymphs, B. divergens could
only be detected in one out of eleven assayed ticks.
Conclusions: The nested PCR provides the means to study tick transmission
of B. divergens. It allows the detection of the parasite at very low
parasitaemias in blood and also detects them in unfed nymphs, suggesting
for the first time that larvae may be capable of acquiring transmittable
infections.
IWeP262I Presence of the Ehrlidlia phagocytophila
genogroup in Ixodes ridnus and human sera
J. A. Oteo, A. Perez,J. R. Blanco, V. Martinez de Anoia, H. Gil, A.
Garcia, S.Jimenez, M. Barral. R.Juste
Direction General de Salud, Gobierno de La Rioja & NEIKER-SIMA,
Logrono, Spain
Objective: Human Granulocytic Ehrlichiosis (HGE) is an emerging infec-
tious disease. The HGE agent is closely related to E. equi and E. phagocyto-
phila, and is transmitted by ticks of the genus Ixodes. We wish to know the
presence ofthe HE in ticks and human in La Rioja, an endemic area for Lyme
disease in the Nonh of Spain.
Material and Methods: We have collected and investigated by PCR specific
to the E. phagocytophila group DNA in I. ricinus ticks and the presence ofthe
HGE agent using an IFI test. A set ofprimers using as target the 16S rRNA
sequence of the granulocytic ehrlichia (E. equi, E. phagocytophila and the
HGE agent) (El: 5'-GGC ATG TAG GCG GTT CGG TAA GTT-3/, and
E2: 5'-CCC CAC ATT CAG CAC TCA TCG TIT A-3') amplifying a 262
bp product specific to the E. phagocytophila genogroup was used in all the
PCR tests. Adult ticks were processed individually and nymphs and larvae
were pooled, each pool containing ten and hundred individual. respectively.
Results: We have analyzed a total of6,870 I. nicinus ticks and 147 human
serum samples. Of the I. ricinus analyzed, 5.3% ofadults and 24.1 % of the
nymphs pools carried E. phagocytophila DNA. In human. 1.4% of sera
reacting in the IFI test.
Conclusion: There is a high prevalence ofE. phagocytophila genogroup in the
main vector ofHGE infection (I. ricinus). We have also found HE infection
in human sera.
IWeP263I Presence of the Ehrlichia phagocytophila
genogroup in other ticks different of Ixodes ridnus. An
epidemiological analysis of vectors
J. A. Oteo, H. Gil, S. Jimenez, M. Barral, A. Garcia, A. Perez, J. R.
Blanco, R. Juste
DirecciOn General de Salud, Gobierno de La Rioja & NEIKER-SIMA,
Logrono, Spain
Objecthle: Human Granulocytic Ehrlichiosis (HGE) is an emerging infec-
tious disease. The HGE agent is closely related to E. equi and E. phagocyto-
phila, and is transmitted by ticks of the genus Ixodes. Our aim is to know
whether other ticks different to the genus Ixodes are infected by this bacterias.
Material and Methods: We have collected and investigated by PCR specific
to the E. phagocytophila group DNA, different types of ticks not associated
with the genus Ixodes. The ticks were collected in La Rioja (Spain), an
endemic area for Lyme disease. A set of primers using as target the 16S
rRNA sequence of the granulocytic ehrlichia (E. equi, E. phagocytophila and
the HGE agent) (El: 5'-GGC ATG TAG GCG GTT CGG TAA GTT-Y,
and £2: 5'-CCC CAC ATT CAG CAC TCA TCG TIT A-3') amplifying a
262 bp product specific to the E. phagocytophila genogroup was used in all the
PCR tests. Adult ticks were processed individually and nymphs and larvae
were pooled. each pool containing ten and hundred individual, respectively.
Results: A total of2,221 non-Ixodes ticks were analyzed: 2,161 Haemaphy-
salis sp, 20 Dermacentor sp and 40 Rhipicephalus sp. Of Haemaphysalis sp, in
10% larvae, 3.9% nymphs and 5.9% adults was detected peR specific to the
E. phagocytophila group DNA. In adults, PCR specific to the E. phagocyto-
phila group DNA was detected in 5% of Dermacentor sp and 2.5% of
Rhipicephalus sp.
Conduslon: There is a high prevalence ofE. phagocytophila genogroup in the
ticks analyzed in our community. We need to know better wich is the role of
these ticks in the epidemiology of the HE infection and if they are potential
vectors for the HE infection.
IWeP264IThree acute cases of human granulocytic
ehrlichiosis recognized in Poland
S. Tylewska-Wierzbanowska, T. Chmielewskil • M. Kondrusik2, T.
Hermanowska-Szpakowicz2, W. SawickiJ , K. SuJtekJ
I National Institute ofHygiene, Warsaw; 2Department ofNeuroinfeltions,
Medical Academy, Bialystock; 3Department of Internal Medicine &
Hematology, Military Medical Academy Hospital, Warsaw, Poland
Objectives: Laboratory confirmation of three clinically recognized acute
cases of human granulocytic ehrlichiosis.
Methods: Level ofserum antibodies to E. phagolytophila group antigens was
measured with indirect immunofluorescence assay (MRL Diagnostics,
USA). Presence of ehrlichial DNA was detected by PCR technique.
Peripheral blood smears were examined for presence ofinclusions (morulae).
Results: Three patients with fever ofunknown origin tested for ehrlichiosis
have shown elevated levels of IgM (1 patient), IgG (1 patient) serum
antibodies to E. phagoeytophila group antigens and positive PCR (2 patient)
Conclusion: According to CDC case definition of ehrlichiosis one of the
following laboratory criteria must be fulfilled: (1) presence of appropriate
level of serum antibodies or seroconversion (2) positive peR (3) inaaeyto-
plasmic inclusions and low level of antibodies. Presented cases can be
classified as follow: 2 - confirmed granulocytic ehrlichiosis, 1 - prohable case.
IWeP26S1 Mediterranean spotted fever IMSfI - An emerging
infection in Bulgaria
N. Popivanova
Medical University, Plovdiv, Bulgaria
In 1999 we concluded a 7-year follow up of the MSF which emerged in
Plovdiv and the environs, after 20 years of eradication.
Objectives: To define the recent clinical peculiarities ofMSF focusing on the
organ injuries.
Methods: 86 patients with MSF were recruited for the study. Indirect IFA
was used for etiological evaluation. (Referent rickettsiallab.-Sofia)
Results: In 26 pts. (30.23%) pulmonary inflammation was present. Hepa-
tomegaly was found in 63 pts. (73.25%). Jaundice had 11 ofthem-12.79%.
ALT/ASTwere quite often increased: 43.83%. Acute renal failure occurred
in 7 pts. (8.13%). Decreased sodium level in the serum was found in 51.16%.
Myocarditis was diagnosed in 4 pts. Neurological complications were noted
too: serous meningitis and/or encephalitis, polyradicu1oneuritis, GuiIlain-
Barre syndrome. Hemorrhagic thromboangiitis, thrombocytopenia and
hemorrhagic diathesis with gastrointestinal bleeding were observed. The
lethal outcome in MSF (5 pts.) results from multiorganic lesions mainly in
elderly patients.
Conclusions: Although benign in the most frequent moderate forms, MSF
may be accompanied by large organ disorders and fatal outcome.
!WeP266I Characteristics of Mycoplasma pneumoniae
pneumonia in children
S. Esrosito, F. Blasi!, L. Fagetti!, M. Alessil , L. Fioravanti, V. Popescu
Janu ,R. Droghetti, L. Allegra!, N. Principi
Paediatr Dept IV, L. Sacco Hosp, Univ. Milan; 'Inst Resp Dis, IRCCS
Maggiore Hosp, Univ Milan, Italy
To distingnish characteristics of Mycoplasma pneumoniae (Mpn) pneumonia,
the clinical signs, symptoms, host responses and radiographic patterns were
studied in 68 children with pneumonia in presence of acute Mpn infection
and in 116 subjects with pneumonia but no evidence of Mpn infection.
Aetiologic diagnosis was based on antibody assays in paired sera (IgM and
IgG to Mpn) and polymerase chain reaction in nasopharyngeal aspirates.
Chest radiographs were performed on admission and were reviewed by a
paediatric radiologist blinded to the children's diagnosis. No combination of
clinical signs and symptoms could be shown to differentiate Mpn pneuma-
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nia. Also duration of illness and hospitalization were similar between the
groups. The host response ranged widely: the mean erythrocyte sedimenta-
tion rate did not dilfer significantly between the groups; neither did white
blood cell nor dilferential count or C-reactive protein. Unilateral reticula-
nodular infiltrate was observed significantly more commonly in children
with acute Mpn infection (27{68, 39.7%) than in those without acute Mpn
infection (17{116, 14.7%; P = 0.00(2). On the contrary, no significant
dilferences were observed between children with and without acute Mpn
infection as regards prevalence of hyperinflation, peribronchial thickening,
perihilar linear opacities, segmental or lobar consolidation, bilateral diffUse
consolidations and pleural effusion. Our study shows that in children Mpn
pneumonia is characterized by specific fmdings in only a minority of cases,
whereas often clinical, biological and radiographic data do not predict
causative agents precisely.
IWeP267I Persistent Chlamydia pneumoniae infection in
COPD (chronk obstructive pulmonary disease) patients
E. Mazurl,J. NiedZwiadekl,J. Chtniclewska-Badora3, B. Gryglicka2, G.
Polakl,J. Ligi~l,M. Koziol-Montewkal,J. Milanowski2
'Department of Medical Microbiology; 2Department ofPulmollary Medicille,
Ulliversity School ofMedicille; JDepartment ofZoollotic Illfec'iolls, Institute of
Agricu/lllre Medicine, Lublin, Switzerlalld
Recent studies have indicated a possible association between persistent
Chlamydia plleumOlliae (Ch. p) infection and several chronic diseases, includ-
ingCOPD.
Objectives: The aim ofour study was to evaluate the frequency ofpersistent
Ch. p. infection in COPD patients by measuring Ch. p.-specific serum IgG
and IgA levels. 70 COPD patients and 39 healthy controls have participated
in the research.
Methods: Microimmunofluorescence method has been applied. Chlamydia
plleumoniae Micro-IF test (Labsystems) has been used. According to the
reference data, the criteria for persistent Ch. p. infection have been defined as
IgG titer 2: 1:128 and, simultaneously, IgA 2: 1:32.
Results: 64.1 % ofCOPO patients and 20.5% of healthy controls appeared
to be chronically infected with Ch. p. (p < 0.001). Taking in account COPD
category, persistent Ch. p. infection has occured in 68.2%, 57.1 %. and
50.0% of patients with severe. moderate and mild COPD. respectively.
Condusions: Our study has revealed that persistent Ch. p. infection occurs
more frequently in COPD patients than in healthy controls and in patients
with severe COPD than in ones with mild and moderate disease.
IWeP26S1 Chronic Chlamydia pneumoniae infection in
asthma patients
J. NiedZwiadek l • I. Musik3, E. Mazurl , J. Chmielewska-Badora4, G.
Polak' ,J. Ligi~I , M. Koziol-Montewka1, J. Milanowski2
'Department ofMedical Microbiology; 2Department ofPulmollary Medicine;
JDepartment ofChemistry, University School ofMedicille, Lublill; 'Department
of Zoonotic IllfectiOllS, Institute ofAgriculture Medicine, Lublin, Poland
Recent studies have indicated a possible association between chronic
Chlamydia p"eumolliae (Ch.p) infections and several inflammatory diseases,
including asthma.
Objectives: The aim of our study was to evaluate the frequency of chronic
Ch.p. infection using serologic criteria and ascertain the presence ofCh.p. in
upper respiratory tract in asthma patients. 41 asthma patients and 35 healthy
controls have participated in the research.
Methods: Microimmunofluorescence and PCR methods have been
applied. Chlamydia p"eumo"iae Micro-IF test (Labsystems) has been used to
measure Ch.p.-specific serum IgG and IgA levels. According to the reference
data. the criteria for chronic Ch.p. infection have been defined as IgG titer 2:
1:128 and. simultaneously. IgA 2: 1:32. The presence of Ch.p. in upper
respiratory tract has been detected using PCR method.
Results: 56.1 % of asthma patients and 11.4% ofhealthy controls appeared
to be chronically infected with Ch.p. (p < 0.001) according to serologic
criteria. Taking in account asthma category, chronic Ch.p. infection has
occurred in 56.3%. 71.4%. and 36.4% ofpatients with severe. moderate and
mild asthma, respectively. In 7 (17.9%) asthma patients and in I (3.5%)
healthy control DNA of Ch.p. has been detected by PCR method.
Conclusions: Our study has revealed that persistent Ch. p. infection oecurs
more frequently in asthma patients than in healthy controls and in patients
with ~vere ~nd moder2te ~sthm~ th~n in ones with mild di~~.
IWeP269! Chlamydia pneumoniae and Mycoplasma
pneumoniae serologkal findings of infection and IL-12
concentrations in patients with multiple sclerosis (MS)
J. Truchlinskal • M. Koziol-Montewkal , Z. Stelmasiak2, A. Sidor-
Wojtowiczl , B. Dobosz2, A. Witkowski!
'Microbiology [Hpartment; 2Neurology Department of University Medical
School in Lublin, Poland
Objectives: Participation ofautoreactive T cells in demyelinating processes
in patients with multiple sclerosis (MS) implicates in some cases dilferent
tnicroorganism antigenic activation and intrathecal cytokine production.
The aim ofthe study was to investigate the frequency ofserological findings
ofChlamydia pneumoniae (C.p.) and Mycoplasma plleumoniae (M.p) infection
in patients with MS in comparison to IL-12 concentration, the cytokine
regulating the balance of immune response.
Methods: Study group covered 40 patients with MS diagnosed according to
Poser's criteria. Serum and cerebrospinailluid antibodies against C.p. and
M.p. were detected using IF and ELISA methods.
Results: Diagnosticly significant levels of C.p. antibodies have been found
in 9 pts (22.5%) and in 11 others (27.5%) antibodies against M.p. were
present. IL-12 serum concentrations were not significantly dilferent in
seropositive patients vs. seronegative pts. IL-12 concentrations in cerebrosp-
inal fluid were significantly higher in seronegative Mycoplasma pneumolliae
patients (273 pg{ml vs. 92.1).
Coclusions: Autoreactivity of T Iimfocytes in MS patients can be
influenced by Chlamydia plleumoniae and Mycoplasma pneumoniae infections
and modulated by IL-12 production.
IWeP270IMeningoencephalitisln a newbom caused by
maternal Mycoplasma hominis
M. Knauszl , E. D6sa2, T. Niederlandl , E. Nagy2, F. Rozgonyi3
IClillical Microbiology Laboratory, Newborll Ward, Aladar Petz County
Hospital, Gyiir; 2Central Microbiology Diagnostic Laboratory, Scientific
University ofSzeged, Szeged; Jlllstilllte ofMicrobiology, Semmdweis
Ulliversity, Budapest, Hungary
Objectives: A urogenital Mycoplasma homillis infection was transferred from
a mother to her newborn causing meningoencephalitis.
Case report: A ten-day male newborn had become febrile and vomited.
He had been treated with amoxicillin and paracetamol for six days without
success, therefore, was admitted to the Hospital. Bacterial cultivations of
nosc and throat swabs wcrc ncgatives. Upon i.v. ampicillin and clectrolyte
treatment he became rehydrated and apyretic. After eight days tonic-clonic
seizures and dissociated eye movements arose. Cerebrospinal fluid (CSF) was
opalescent. full of white blood cells but no bacteria were seen by Gram
staining. No antigens could be detected in CSF by the Wellcogen Kit.
Ceftiaxone was given as empirical therapy. Anaerob cultivations of the CSF
on Columbia agar resulted in tiny rounded colonies by the 3rd day of
incubation The bacteria were unstainable and multiresistant except for
chloramphenicol (2 JJg{ml), doxycycline (1 JJg{ml) and olloxacin (1 JJ8{
mil. In Mycoplasma 1ST it was identified as M. hominis. The same was
grown from the cervix and urine of the mother. Hemocultures ofthe infant
in Vital bottles were negatives. The infant received ventricular drainage and
chloramphenicol i.v. for three weeks. then a ventricular-peritoneal shunt
was necessary to implant. He was discharged in a good developing condition
three months later.
Condusions: M. hominis also may cause newborn sepsis and meningitis. This
is the 1st Hungarian report on it.
IWeP271I Neurological complications oftick-bom
encephalitis kaunas 3 -ret dlnlcal hospital. Department of
Vertebroneurology
J. Marengolcas
Kaunas 3 -rd Clinical Hospital, Departmellt ofVertebroneurology, Kaunas,
Lithuania
Object: To demonstrate the patient. who recovered of tick - born encepha-
litis (poliomyelitic form) with severe lesion ofneurotrophicity.
Methods: We looked through the case of history. The patient A.M., 59
years old. was ill with tiek - born encephalitis in 1997.08. The patient hecawe
ofcomplications and remaining episodes w:!s hospitali2ed to the department
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of vertebroneurology. The patient complained of weakness, numbness,
freezing, of both hands' especially of the right hand, and pain in the back
of the head. Neurological examination showed: converging strabismus
(strabismus convergms). No tendon reflexes in the right hand, in the left
hand (+) positive. Patellar and Achilles reflexes are more elevated. The
patient cannot move the right hand and there are weak flexible movements
of III finger and right shoulder. There is the muscular atrophy of the right
shoulder and the whole right hand. Taking hand up in the air is limited, the
power ofpalm ofthe hand is weaken. There contractures in the joint of the
both shoulders. The neck's movement to the lift ant to the right sides are
limited. Hypesthesia in the both hands in the of C5 and C6 nervous root
projection. No pathologic reflexes noticed. The skin is cyanotic and rough in
the right hand.
Treatment: Pentoxityllinum, Vitamins B12, B6, Neostigmin, physiother-
apy, kinesitherapy.
Conclusions: Tick - born encephalitis is rear disease, but still it gives to know
about itsdf. It causes severe health problems and complications. and treat-
ment not always is successful.
IWeP212! Morbility and prophylaxis tick-borne encephalitis
(TBE) among children in Kaunas District Uthuania
V. MaCioniene, R. MaCionis, S. Panavas
Hospital of Infectious Diseases Kaunas, Lithuania
Ojectives: To analize TBE clinical forms and the rate of vaccination against
TBE among children in Kaunas district.
Methods: The epidemiological, clinical characteristics and laboratory con-
firmation of all TBE patients that have been treated for TBE in Kaunas
Hospital ofinfectious Diseases were analized for the five years period (1995-
1999).
Results: There have been diagnosed 70 cases ofTBE. Tick bites and the use
ofinfected milk (row goats' or caws') havc takcn placc cven in the 78.5% of
all cases. The alimentary route of infection prevailed in family cases. There
were 63.7% ofgirls and 36.3% boys, prevailing age 3-15 years. Among the
clinical manifestation of disease the headacke (91.8%), weakness (93.4%),
vomiting (86.5%), increased temperature (100%) were most frequent. The
fever was two waved in 52.3% ofcases. More frequent clinical forms were
meningitis (72.4%) and meningoencephalitis (18.2%). The diagnosis was
confirmed for all the patients by detecting TBE IgM antibodies in sera. 3021
children have been vaccinated against TBE using BAXTER-IMMUNO
vaccine.
Condusions: I. TBE is a problem of great significance for adults and
children in Lithuania.
2. The only prophylaxis measure against TBE is vaccination using
(BAXTER-IMMUNO) vaccine.
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IWeP213I Nontoxigenic sorbitol-fermenting Escherichia coli
0157:W2 associated with a family outbreak
F. Allerbergerl , U. Gmber-Moesenbacher2, G. Hartmann2, H. TschapeJ.
H. Karch4
tBundesst. Bakt.-Serol. Untersuchungsamtalt, Innsbruck; 2Krankmhaus
FelJkirchAustria; JRobert Koch-Institut, WernigeroJe; 4Institutftir Hygiene unJ
Mikrobiologie, Wjjrzburg, Germany
Objectives: Characterization of 6 sorbitol-fermenting E. coli 0157:H-
isolates that do not contain Shiga toxin genes.
Results: Isolates originated from an outbreak (3 patients, 3 asymptomatic
contacts) of non-bloody diatthea affecting two families sharing one house-
hold. Two children (age 10 months and 2 years) suffered severe diatthea over
30 and 10 days, respectively. Their uncle had moderate diatthea, for 2 weeks.
Contrarily to the other isolates, the uncle's strata did not harbor a chromo-
somal eae gene and not the plasmid gene E-hly; it also showed a PFGE
pattern which was different from the unique pattern of the other isolates.
Employing PFGE, Iysotyping, and P-gene ryping, five of these six [stx
negative!) isolates were indistinguishable from the [stable stx 2 positive!]
"Bavarian outbrcak .train". The only human serum tested, obtained from
one asymptomatic contact. contained antibodies to the 0157 lipopolysac-
caride antigen.
Conclusions: Our finding of five sorbitol-fermenting E. coli 0157:H-
isolates harboring eaeA and E-hly associated with an outbreak of non-
bloody diarrhea .upport. the hypothesis, that Stx may not necessarily be
produced by E. coli 0157 stratus associated with human disease. Whether the
Austrian stx negative clone is an ancestor of or a successor to the Bavarian
clone remains unanswered.
IWeP214IResistance to third generation cephalosporins
remains low in dinical isolates of Klebsiella pneumoniae and
Escherichia coli in the Netherlands
W. Goettsch, A. J. de Neeling
RIVM Bil/hoven, Ne/herlands
Objectives: To study resistance to third generation cephalosporins in
Klebsiella pneumoniae and Escherichia coli.
Methods: In ongoing surveillance of routine samples in seven Dutch
laboratories (Arnhem, Enschede, Haarlem, Heerlen, Leeuwarden, Nijme-
gen, Tilburg), resistance to third generation cephalosporins (cefotaximc or
ceftazidime) was investigated in 65,000 E. coli and 11,000 K. pneumoniae
hospital isolates.
ResuIts: Resistance to these compounds remained low; from 0.2% in 1989
to 0.7% in 1999 in E. coli and from 1.1 % in 1989 to 1.6% in 1999 in K.
pneumoniae. When the resistant strains were studied in more detail, it became
clear that these strains were often multi-resistant: Next to high resistance
against co-trimoxazole (30-40%), especially K. pneumoniae was also fre-
quently resistant against gentamicin (> 20%). Most alarming however, was
the increasing resistance against ciprofloxacin. Especially in K. pneumoniae
f1uoroquinolone resistance increased from 0% (1989-1996) up to 20% in
1999. We did not find any resistance against carbapenems (imipenem).
Conclusions: The production ofbeta-Iactamases in K. pneumoniae and E. coli
is still at a low level and that most infections with these pathogens can still be
treated with the help of (third generation) cephalosporins. Nevertheless,
there are indications that. when an occasional outbreak with cephalosporin
resistant K. pneumoniae occurs, treatment opportunities become more
limited.
IWeP21S1 Oinical and bacteriological characterization of
Actinobacillus homlnls, a new pathogen In immunosuppressed
patients
A. Friis-Mollerl ,].]. Christensen2, V. Fussing2, B. Bruun2
l Depts ofClin. Microbiology H:S HviJovre Hospital; 2Statens Serum lnstitut,
Copenha)len, Denmark
0bjectIYes: The aim of this study was to give clinical data of patients
infected with Actinobacillus hDminis, a rarely recognized pathogen from the
family Pasteureltaceae, and to characterize the bacterium pheno- and geno-
rypically.
Methods: A retrospective study was performed on 38 patients from
Copenhagen with A. hominis isolated from lower respiratory specimens,
pleural fluid and from blood. These isolates and 6 isolates from other
countries, together with 20 strains (including type strains) of related
Pasteureltaceae taxa, were characterized conventionally, and by the ID32
and Vitek automatic identification systems, as well as by riboryping and by
DNA-DNA hybridization.
Results and: conclusions: The role of A. hominis as a human pathogen in
patients with severe immunosuppression and chronic lung disease was
demonstrated. Conventional bacteriological characterization and ribotyp-
ing showed a very homogeneous species, distinct from related Pasteureltaceae
taxa. Identification by the ID32 and Vitek systems was not possible, as these
systems inter alia do not contain this species in their databases. DNA-DNA
hybridization also demonstrated a well circumscribed and homogeneous
species.
IWeP216I Persistent abdominal pain caused by Leptospira
Interrogans
M. Dalamaga, A. Kostoula, C. Chavelas, A. Matekovits, G. Antoniades
Microbiology Department. Ioannina University Hospital, 45 110 Ioannina,
Greece
Objective: To point out the possible diagnosis of Leptospirosis in patients
with persistent abdominal pain.
Methods and MaterIals: We report a case of a white man, 21 years old,
performing his military service, who presented at the Emergency Unit of
